The EMA is working with social media content creators to try to encourage "safe and responsible" use of weight-loss drugs.

A boardroom shake-up at Novo Nordisk has handed unprecedented power to its top shareholder, the Novo Nordisk Foundation, ...

Dubbed the 'world's biggest raid', the MHRA said it was also the first illicit production facility for weight loss medicine ...

Another week, another twist in the turnaround efforts at Novo Nordisk, the maker of the blockbuster Ozempic and Wegovy weight ...

On October 23, Lilly and Mumbai-based Cipla announced a joint agreement to distribute and promote tirzepatide under the brand ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

The chairman of Novo Nordisk and six other independent board members quit on Tuesday after a dispute with the company’s ...

Eli Lilly's rival Novo Nordisk plans to retail both Ozempic and Wegovy in India as diabetes and weight-loss drugs, respectively.| Business News ...

US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...

Get the daily news here. Read the essential Danish news and topics of today - in English. Politiken Edition is your window to Denmark.